UBE2C Drives Human Cervical Cancer Progression and Is Positively Modulated by mTOR
Cervical cancer is a common gynecological malignancy, accounting for 10% of all gynecological cancers. Recently, targeted therapy for cervical cancer has shown unprecedented advantages. Several studies have shown that ubiquitin conjugating enzyme E2 (UBE2C) is highly expressed in a series of tumors,...
Enregistré dans:
| Auteurs principaux: | , , , , , , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
MDPI AG
2020-12-01
|
| Collection: | Biomolecules |
| Sujets: | |
| Accès en ligne: | https://www.mdpi.com/2218-273X/11/1/37 |
| Tags: |
Pas de tags, Soyez le premier à ajouter un tag!
|